The Relationship Between Small Dense Low-Density Lipoprotein Cholesterol and Metabolic Syndrome
DOI: https://doi.org/10.2147/dmso.s450783
2024-03-31
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Xiaoli Zhu, 1 Yijun Chen, 1 Mingan Zhu, 2 Jinxi Hu 3 1 Department of Laboratory Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, People's Republic of China; 2 Department of Medical Laboratory, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China; 3 Department of Oncological Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, People's Republic of China Correspondence: Mingan Zhu, Department of Medical Laboratory, Renmin Hospital, Hubei University of Medicine, No. 39 Chaoyang Middle Road, Shiyan, Hubei Province, 442000, People's Republic of China, Tel +86 13872767288, Email Jinxi Hu, Department of Oncological Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, No. 150 Ximen Road of Linhai, Taizhou, Zhejiang Province, 317000, People's Republic of China, Tel +86 18257689350, Email Background: Prior research has established an association between small dense low-density lipoprotein cholesterol (sdLDL-C) and dyslipidemia, serving as a significant marker for predicting cardiovascular diseases. Nevertheless, the connection between sdLDL-C and metabolic syndrome (MetS) remains unclear. Methods: This study retrospectively analyzed 23,187 individuals who underwent health checkups at Taizhou Hospital's health management center. Here, we investigated the relationship between sdLDL-C and MetS, along with its components, utilizing Spearman correlation analysis, receiver operating characteristic (ROC) curve analysis, logistic regression, and mediation analysis. Results: The MetS group exhibited significantly higher level of sdLDL-C compared to the non-MetS group ( P < 0.001). We observed a strong correlation between sdLDL-C and several key factors: TG (r = 0.711), TC (r = 0.672), LDL-C (r = 0.781), GGT (r = 0.420), and HDL-C (r = − 0.417). After adjusting for age and gender, the odds ratio (OR) (95% confidence interval [CI]) for MetS incidence in the second, third, and fourth quartiles versus the first quartile of sdLDL-C concentration were 2.264 (95% CI: 1.851, 2.770), 4.053 (95% CI: 3.350, 4.903), and 9.034 (95% CI: 7.531, 10.837). The optimal cut-off value for diagnosing MetS using sdLDL-C was determined to be 0.98 mmol/L, with an area under the ROC curve (AUC) of 0.716 (95% CI: 0.705, 0.726). Additionally, mediation analysis revealed that sdLDL-C mediated a 12.8% correlation between GGT and TG concentration. Conclusion: The sdLDL-C is correlated with MetS and it can successfully mediate the relationship between GGT and TG. Our data suggests that sdLDL-c and GGT are suitable parameters for preventing and monitoring MetS. Keywords: metabolic syndrome, small dense low-density lipoprotein cholesterol, mediation analysis, GGT Metabolic syndrome (MetS) is a group of clinical syndromes characterized by central obesity, impaired glucose regulation, or diabetes, lipid metabolism disorder, and hypertension, with insulin resistance (IR) as the common pathophysiological basis. 1 MetS not only increases the risk of cardiovascular disease (CVD) and diabetes but is also related to potential surging mortality rates of patients diagnosed with CVDs. 2,3 Related research shows that MetS patients have a 5-fold higher risk of type 2 diabetes and a 3-fold higher risk of stroke and myocardial infarction than healthy subjects. 4 According to currently available epidemiological data, in most countries around the world, 20% to 30% of adults suffer from MetS, and there is still a growing trend of affected individuals fighting against this condition. 5 The pathogenesis of MetS remains unclear. IR is considered to be the core of MetS, and obesity, abnormal fat distribution, leptin, tumor necrosis factor, adiponectin, oxidative stress, and other inflammatory factors also play a certain role in the occurrence and development of the syndrome. 6–8 In addition, these related mechanisms may vary depending on age. 9,10 The components of MetS are not isolated; they interact with each other. In MetS, dyslipidemia is associated with IR and type 2 diabetes, 11 and diagnosed obese patients are often accompanied by dyslipidemia. 12 Abnormal blood lipids, including elevated levels of sdLDL-C, triglycerides (TG), very low-density lipoprotein (VLDL), and apolipoprotein-B, as well as decreased levels of high-density lipoprotein cholesterol (HDL-C) 12 can also be considered diagnostic components of MetS, especially high TG and low-level HDL-C. SdLDL-C levels are often elevated in MetS patients, but their impact on MetS has no -Abstract Truncated-
endocrinology & metabolism